Overview

Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if treatment with the drug liposomal vincristine can shrink or slow the growth of the patient's cancer. The safety of this drug will also be studied.
Phase:
Phase 2
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborator:
Inex Pharmaceuticals
Treatments:
Vincristine